Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Characterization of Advanced Stage Melanoma by Blood Sampling

NCT02862743 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT02862743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02862743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Characterization of Advanced Stage Melanoma by Blood Sampling
Lead sponsor
CHU de Reims
Phase
Not applicable
Overall status
Completed
Start date
January 14, 2016
Completion date
December 31, 2019
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma